Signifier Medical Technologies Secures Series B Funding to Advance Non-Invasive Therapy for Obstructive Sleep Apnea

VCBeat (WeChat ID: vcbeat) learned from foreign media that on June 17, Signifier Medical Technologies completed its Series B financing, with the amount undisclosed. The round was led by Pritzker Organization, with Baxter International participating as a follow-on investor. The funds will be used to accelerate the company’s R&D of innovative therapies for sleep-disordered breathing and to promote its treatment devices for obstructive sleep apnea.

Signifier Medical Technologies, formerly known as Snoozeal, is an innovator in the market for sleep-disordered breathing treatments. The company is dedicated to improving the lives and sleep quality of patients with sleep-disordered breathing, namely snoring and obstructive sleep apnea. As a challenger to conventional therapies for sleep-disordered breathing, Signifier Medical Technologies physiologically trains patients’ breathing to prevent airway collapse. A team of highly skilled professionals from fields including sleep medicine, maxillofacial surgery, product development, medical engineering, and software engineering spent three years developing Snnozeal, a simple-to-use, intuitive, non-invasive device for the treatment of sleep-disordered breathing.

“Over the past few years, we have been dedicated to developing a device for the treatment of snoring and mild obstructive sleep apnea,” said Anshul Sama, Founder and Chief Medical Officer of Signifier Medical Technologies. “This device has the potential to address or alleviate symptoms of mild obstructive sleep apnea for more than 200 million people in the United States and Europe. We are leveraging proven technologies to expand our commercial pipeline, while simultaneously accelerating the research and development of cutting-edge products. Our goal is to help patients escape the suffering caused by obstructive sleep apnea.”

Joseph Gleberman, Managing Director of the Pritzker Organization, stated, “The devices developed by Signifier Medical Technologies are versatile and effectively alleviate patients’ symptoms, enabling countless individuals to enjoy a healthy and worry-free lifestyle.”

Since 2015, Signifier Medical Technologies has been raising funds, with total financing reaching $13 million, including its Series B round.

Pritzker Organization is a private firm engaged in investment, acquisitions, and corporate operations, with core services including M&A advisory, business valuation, business consulting, corporate management, and enterprise management consulting. The company’s team possesses extensive experience in investment and acquisitions, enabling it to deliver relevant services to clients. The company’s objective is to maximize value without transaction friction costs and to invest in projects that create long-term value.

Baxter International is a global medical supplies company specializing in the treatment of chronic and critical conditions. It develops, manufactures, and markets products worldwide for complex and severe conditions such as hemophilia, immune system disorders, infectious diseases, cancer, renal diseases, and severe trauma. To date, Baxter International has established more than 250 companies and branches in over 100 countries, operates more than 60 manufacturing facilities, and employs over 47,000 people globally. The company produces and sells more than 100,000 medical products. Its primary business segments are Medication Delivery, Renal Care, and BioScience.

(Compiled by Qu Dandan)